Shenzhen Bioeasy Biotechnology Co. Ltd. Capital Reinvestment Ratio
Shenzhen Bioeasy Biotechnology Co. Ltd. capital reinvestment ratio. Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Capital Reinvestment Ratio of 1.27x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥9.12 Million) in capital expenditures (CN¥11.62 Million). See free cash flow generation of Shenzhen Bioeasy Biotechnology Co. Ltd. to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
Capital reinvestment ratio of Shenzhen Bioeasy Biotechnology Co. Ltd. from 2016 to 2025. This chart tracks Shenzhen Bioeasy Biotechnology Co. Ltd.'s Capital Reinvestment Ratio across 9 annual periods. See 300942 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Shenzhen Bioeasy Biotechnology Co. Ltd. Capital Reinvestment Ratio by Year (2016–2025)
Shenzhen Bioeasy Biotechnology Co. Ltd. capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see 300942 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.69x | CN¥66.87 Million | CN¥45.90 Million | ▼ -86.5% |
| 2024 | 5.08x | CN¥34.26 Million | CN¥174.10 Million | ▲ +338.4% |
| 2022 | 1.16x | CN¥152.55 Million | CN¥176.85 Million | ▲ +272.4% |
| 2021 | 0.31x | CN¥255.42 Million | CN¥79.51 Million | ▼ -76.0% |
| 2020 | 1.30x | CN¥63.79 Million | CN¥82.84 Million | ▲ +232.1% |
| 2019 | 0.39x | CN¥67.24 Million | CN¥26.29 Million | ▲ +115.1% |
| 2018 | 0.18x | CN¥57.93 Million | CN¥10.53 Million | ▼ -60.3% |
| 2017 | 0.46x | CN¥23.60 Million | CN¥10.82 Million | ▲ +84.4% |
| 2016 | 0.25x | CN¥36.31 Million | CN¥9.03 Million | — |